Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Physitrack

9.20 SEK

-0.86 %

Less than 1K followers

PTRK

First North Stockholm

Software

Technology

-0.86 %
-13.62 %
-29.77 %
-27.56 %
-54.68 %
-38.05 %
-42.14 %
-
-80.22 %

Physitrack operates in the healthcare sector and specializes in physiotherapy. The product portfolio includes digital healthcare offerings for companies via SaaS solutions. In addition to the main business, personal service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe and North America. Physitrack was founded in 2012 and is headquartered in London.

Read more
Market cap
149.6M SEK
Turnover
161.21K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23.4.
2026

Interim report Q1'26

26.6.
2026

General meeting '26

21.7.
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
The journey continues in the same direction after a good Q2. Profitability and cash flow are developing, and the closure of low-margin clinics reduces revenue as expected. One-off restructuring costs are still visible, of course. One-off costs out of the figures going forward and...
10/21/2025, 6:24 AM
by kettunen
5
Physitrack PLC Announces Appointment of new Head of Sales, North America Physitrack PLC today announced the appointment of Yanni Metaxas as its new Head of Sales for North America, effective 1 September 2025. Metaxas joins Physitrack from Mount Sinai Health System in New York City...
8/28/2025, 2:38 PM
by kettunen
5
A Q4 update fairly in line with expectations. Official and audited figures will follow later. Growth is needed; profitability is significantly better. storage.mfn.se pdf-report-physitrack-plc-unaudited-fy2025-trading-update-and-preliminary-results.pdf CEO Henrik’s interview https...
1/29/2026, 8:02 AM
by kettunen
2
Redeye’s more extensive comments redeye.se Physitrack (Q3 Review): Staying on track with solid profitability and cash flow Redeye has updated its estimates following Physitrack’s Q3 2025 report, which was broadly in line with expectations. The quarter showed continued margin strength...
10/22/2025, 5:54 AM
by kettunen
2
Redeye’s Q3 preview on Oct 21. Profitability should be improving, with price increases in Lifecare. But Wellness is expecting larger contracts in addition to the aforementioned insurance company deal. redeye.se Physitrack Q3 Preview: Profitability momentum continues despite Wellness...
10/6/2025, 5:43 AM
by kettunen
2
B2C has been on the agenda for some time, now the first public steps in that direction The sums here are small, but there is growth potential in the market. Similar steps can probably be taken in the US market over time Physitrack Plc announces deal with European insurer to launch...
9/25/2025, 12:19 PM
by kettunen
2
Physitrack starts share buybacks, as cash flow is finally healthy and valuation is low Physitrack PLC announces intention to implement share buyback program Physitrack’s Board of Directors has approved the intention to implement a share buyback program (the “SBB”), subject to lender...
2/20/2026, 8:40 AM
by kettunen
1
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.